By the end of 2018, more than 26 million consumers had undergone direct-to-consumer (DTC) genetic testing. These genetic tests promise to identify medically relevant genetic variants, identify a consumer’s genetic

A growing body of evidence has linked pharmacogenomic (PGx) testing to better patient outcomes, lower healthcare costs, reduced hospital readmission rates, and prevented adverse drug reactions. Change often comes to

PGx testing has the ability to make a difference in the lives of patients. Here’s one patient story that demonstrates how PGx testing brought her peace of mind.

The Clinical Pharmacogenetics Implementation Consortium (CPIC) is committed to translating pharmacogenomics (PGx) research into actionable prescribing guidelines. In so doing, CPIC aims to standardize PGx testing and

Pharmacogenomics (PGx) has the power to revolutionize health care, save lives, reduce side effects, improve care outcomes, and save money. Illnesses like depression, which have high relapse rates and even higher rates